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Abstract
Development of methods for rapid screening and stratification of subjects after exposure is an
integral part of countermeasures against radiation. The potential demographic and exposure
history-related heterogeneity of exposed populations warrants robust biomarkers that withstand
and reflect such differences. In this study, the effect of aging and repeated exposure on the
metabolic response to sub-lethal irradiation was examined in mice using UPLC-ESI-TOF mass
spectrometry. Aging attenuated post-exposure elevation in excretions of DNA damage biomarkers
as well as N1-acetylspermidine. Although N1-acetylspermidine and 2’-deoxyuridine elevation was
highly correlated in all age groups, xanthine and N1-acetylspermidine elevation was poorly
correlated in older mice. These results may reflect the established decline in DNA damage-repair
efficiency associated with aging and indicate a novel role for polyamine metabolism in the
process. Although repeated irradiation at long intervals did not affect the elevation of N1-
acetylspermidine, 2’-deoxyuridine, and xanthine, it did significantly attenuate the elevation of 2’-
deoxycytidine and thymidine compared to a single exposure. However, these biomarkers were
found to identify exposed subjects with accuracy ranging from 82% (xanthosine) to 98% (2’-
deoxyuridine), irrespective of their age and exposure history. This indicates that metabolic
biomarkers can act as robust noninvasive signatures of sub-lethal radiation exposure.
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Introduction
Mass exposure to ionizing radiation due to sabotage, accident or natural disaster, such as the
2011 earthquake and tsunami in Japan, poses a grave threat to public health. The expanding
landscape of nuclear facilities around the world, which are often located in earthquake-prone
zones or near seashores, and the evolution of extreme weather patterns due to climate
change may increase the risk of radiation leaks in the future. In addition, the establishment
of nuclear facilities in densely populated parts of the world, such as in India, amplifies the
chance of radiation exposure to large number of subjects. The exposed mass would include
individuals with not only different genetic backgrounds but also different ages. In addition,
some people may also have a previous history of sub-lethal radiation exposure. Therefore,
the development of high-throughput biomarkers which are robust against differences in age
and history of exposure is an essential component of countermeasures against ionizing
radiation exposure.
DNA damage signatures, such as gamma-H2AX1 or changes in gene expression, such as
XPC, CDKN1A, GADD45 and MDM22–4 have been proposed as biomarkers for ionizing
radiation exposure. However, the effect of aging and a history of previous exposure on the
robustness and dose-response of these signatures has not been studied in detail. The
importance of examining this interaction is evident from the fact that aging and exposure to
reactive oxygen species (ROS), which may occur due to previous exposure to ionization
radiation, has been shown to modulate a number of pathways involved in DNA damage-
repair5–7. In addition, many of these signatures, including the well established method for
biodosimetry using the dicentric chromosome assay8, are either low-throughput or require
invasive sample collection, which may compromise their utility in case of a mass exposure.
On the other hand, recent studies have shown that ultra-performance liquid chromatography
coupled with electrospray ionization and quadrupole time-of-flight (UPLC-ESI-QTOF)
mass spectrometry-based metabolomic analysis of urine samples can efficiently identify
exposed subjects. This approach is both noninvasive and high-throughput. A subset of these
radiation biomarkers, primarily metabolites arising from DNA damage, were found to be
common across exposed species with wide variation in genetic composition such as
mouse9–11, rat12 and non-human primates13. However, the robustness of these markers
against aging and exposure history has yet to be tested. The metabolome is the result of
intertwined interactions between upstream molecular events and examination of these
interactions may yield novel insights into molecular phenomenon involved in the
modulation of DNA damage response with aging. This study investigates and compares the
effect of aging and exposure history on metabolomic signatures of ionizing radiation
exposure and their implication on biology of DNA damage-repair using mouse model.
MATERIALS AND METHODS
Chemicals
All compounds were obtained from Sigma-Aldrich (St. Louis, MO) and were of the highest
grade available. HPLC grade solvents were purchased from Fisher Scientific (Hampton,
NH).
Animals and Treatments
Twenty-four male 6-week-old wild-type C57BL/6 were purchased from Jackson
Laboratories (Bar Harbor, ME) and acclimated to the animal facility for two weeks. Mice
were fed a regular chow diet and water ad libitum throughout the experiment. Animals were
randomly divided in to four groups (six mice each) at two months of age for radiation
exposure. Mice from sham as well as repeated exposure groups were cohabited. The
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repeated radiation exposure protocol at a regular interval of two months starting at two
months of age is schematically presented in Figure 1A. The groups, namely, Rad-1, Rad-2
and Rad-4 received one exposure (at 8 months), two exposures (at 6 and 8 months) or four
exposures (at 2, 4, 6 and 8 months), respectively (Figure 1A). All mice were acclimated to
the metabolic cages twice before the first urine collection at two months and once before
subsequent collections. At every time point, mice were exposed to 3 Gy gamma radiation
from a 137Cs source in a Mark I Model 68 small animal irradiator (J. L. Shepherd &
Associates, San Fernando, CA) operating at 1.16 Gy/min. Urine samples were collected by
placing mice 2 days prior to (D-2) or immediately after (D0) or 2 days after (D2) radiation
exposure in Nalgene metabolic cages (Tecniplast USA, Inc., Exton, PA) for 24 hours as
shown in Figure 1B. Urine volumes were measured and all samples were stored at −80°C
until further analysis. Animals were regularly monitored for changes in body weight as well
as any sign of deterioration of health. All animal studies were approved by the National
Cancer Institute Animal Care and Use Committee.
Preparation of Urine Samples and Untargeted UPLC-ESI-QTOFMS Analysis
Four volume of 50% acetonitrile containing 5µM chlorpropamide was added to one volume
of urine sample, vortexed, centrifuged, and supernatant was transferred to 96-well sample
plate (Waters Corp., Milford, MA). ESI-MS-based metabolite profiling was performed on a
Waters ESI-QTOFMS (SYNAPT HDMS) coupled with an Acquity UPLC system (Milford,
MA) in both positive and negative ionization mode as described earlier14. Briefly, a 5µL
aliquot of the sample was injected into a BEH C18 column and chromatographic separation
was achieved by an aqueous acetonitrile gradient containing 0.1% formic acid over a 10 min
run with a flow rate of 0.5 ml/min. Column temperature was maintained at 40°C. Capillary
and cone voltages used for ESI-Ms were 3 kV and 20 V, respectively. Source and
desolvation temperatures were 120 °C and 350 °C, respectively. Nitrogen was used as both
cone gas (50 L/h) and desolvation gas (600 L/h). The run also included intermittent injection
of blanks as well as two different quality control samples and all samples were injected in
randomized fashion. Mass chromatograms and mass spectral data (m/z = 50–850) were
acquired using MassLynx software (Waters Corp.) in centroid format.
Multivariate Data Analysis
Chromatograms were manually inspected for consistency in retention time and peak shapes.
MarkerLynx was used for feature identification, deconvolution of chromatogram, and
integration. The area under the peak of each ion was normalized with respect to the total ion
count (TIC) to generate a data matrix that consisted of the retention time, m/z value, and the
normalized peak area. The multivariate data matrix was analyzed by SIMCA-P+ 12.0
software (Umetrics, Kinnelon, NJ). The unsupervised segregation of samples was checked
by principal components analysis (PCA) using Pareto-scaled data15. The supervised
orthogonal projection to latent structures discriminate analysis (OPLS-DA) model was used
to generate loading S-plots for biomarker mining.
Identification of biomarkers
Putative candidates for biomarkers ions were searched using METLIN and HMDB16,17
databases and screened with the help of MS/MS fragmentation patterns. For MS/MS
fragmentation of target ions, collision energies ranging from 10 to 40 eV were applied. The
identities of ions were confirmed by comparison of retention times and fragmentation
patterns with authentic standards. Authentic N1-acetylspermidine was synthesized as
reported earlier12.
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Quantitation of Urinary Metabolites
Quantitation of urinary metabolites was carried out using an AcquityÆ UPLC system
coupled with a XEVO™ triple-quadrupole tandem mass spectrometer (Waters Corp.) by
multiple reaction monitoring (MRM, see Table 1 for details). Standard calibration plots for
quantitation were generated using authentic standards. Deproteinated urine samples
containing 1.0 µM α-aminopimelic acid (176→112; ESI+), were analyzed in the same
fashion as that of authentic compounds. The quantitative abundances were calculated from
the normalized (with respect to internal standard) peak area with the help of the calibration
plot.
Statistics
All values are presented as mean ± standard error of the mean (SEM). Two-way Mann-
Whitney test was performed with 95% confidence interval to evaluate statistical significance
of observed changes in metabolite excretion between sham and irradiated mice using
GraphPad Prism 4 software and p < 0.05 was considered statistically significant. Logistic
regression and ROC analysis for the predictive power of individual biomarkers were
performed using level of urinary excretion of metabolites in sham and exposed animals at
D0. All Logistic regression and ROC analysis was performed in STATA (Stata Statistical
Software Release 11.2, College Station, TX).
RESULTS
Animal Performance
There was no significant change in the overall health and performance of mice irrespective
of the exposure status during the study. The body weights (Figure S1A) and urine volumes
(Figure S1B) of the sham and irradiated animals were also not significantly different.
Multivariate Data Analysis
There was no significant shift in retention times, and mass errors were found to be less than
10 ppm throughout the run. Unsupervised principal components analysis (PCA) showed a
tight clustering of quality control and blank samples (data not shown) indicating consistent
instrument response throughout the runs. PCA of deconvoluted, integrated, total ion count
(TIC)-normalized and Pareto-scaled data from all urine samples collected up to 6 months,
showed that the global urinary metabolomic signatures of the irradiated mice at D0 (24 h
immediately after exposure) was distinct from the sham animals (Figure 1C). The shift in
metabotype upon irradiation was similar (shown by arrow in Figure 1C) irrespective of age
of the mice during irradiation as well as the history of previous exposures. The scores scatter
plots for PCA analysis of urinary metabolomic signature from the Rad-4 group of mice at 2,
4, 6 months and that from the Rad-2 group of mice at 6 months also showed clear
segregation from age-matched sham mice (Figure 1D). The OPLS-DA was performed to
identify ions that contribute significantly to the discrimination of sham and irradiated
animals. The loading S-plots for the discrimination of the Rad-4 group according to
radiation exposure at 2, 4, 6 months and that for the Rad-2 group of animals at 6 months
from age-matched sham mice are shown in Supplemental Figure S2A, B, C and D,
respectively. Ions that contributed significantly to the separation of sham and irradiated mice
in all these analysis were selected for further interrogation. OPLS-DA analysis was also
performed on all sham and irradiated samples together to check the robustness of the
contribution of ions in predicting exposure irrespective age of the animal and number of
previous exposures. The loadings S-plot for the OPLS-DA model on all samples is shown in
(Figure 1E). Finally, the ions that consistently contributed to the separation between sham
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and irradiated mice in all these models were selected as biomarkers for radiation exposure
that could perform robustly against variation in age and exposure history.
Identification of Metabolites
The possible chemical formula of the ions were derived using the Seven Golden Rules18 and
potential candidate metabolites were also identified using METLIN17 and HMDB16
databases using a maximum mass error of 10 ppm (Table 1). Finally, identities of the
metabolites were confirmed by comparing retention time and fragmentation pattern against
authentic standards. Thymidine was identified in both positive (as Na+-adduct) and negative
(as deprotonated ion) mode. All others were identified as corresponding protonated or
deprotonated ions in positive or negative mode, respectively, as shown in Table 1. The
potential metabolic origins of these metabolites are also mentioned in the Table and show
that purine and pyrimidine metabolism was most significantly affected along with arginine
and polyamine metabolism following radiation exposure. All these metabolites were
subsequently quantitated as described above along with putrescine that is the precursor in
polyamine biosynthesis.
Effect of aging and repeated exposure on urinary radiation biomarker excretion
The urinary excretion of 2’-deoxyuridine was elevated by 16.6-fold (p < 0.005), 6-fold (p <
0.005), 5-fold (p < 0.005) and 3.7-fold (p < 0.005) after exposures (D0), respectively, at two,
four, six and eight months of age in the Rad-4 group of mice compared to age-matched sham
mice (Figure 2A). The urinary excretion of 2’-deoxyuridine on D0 at six and eight months
was, respectively, 1.6-fold (p < 0.03) and 2.1-fold (p < 0.04) lower than that at two months
of age. The 2-deoxyuridine excretion at D0 in eight months (p < 0.05) was also 1.9-fold
lower than that at four months of age. The excretion of this metabolite in the Rad-2 and
Rad-1 group of mice after exposure at eight months was 6.9-fold and 5.4 fold higher than
that of the sham mice (Figure 2B). However, 2’-deoxyuridine excretion in the Rad-1 group,
which was freshly exposed at eight months of age, was not significantly different from that
in the age-matched Rad-2 or Rad-4 groups, which, respectively, received one or three
previous exposures. These results indicated that aging, and not repeated exposure,
contributes more significantly to the attenuation in elevation in excretion of 2’-deoxyuridine
following radiation exposure.
2’-Deoxycytidine excretion was elevated by 4.7-fold (p < 0.005), 4.6-fold (p < 0.005), 2.6-
fold (p < 0.02) and 4.4-fold (p < 0.005) after exposures (D0), respectively, at two, four, six
and eight months of age in the Rad-4 group of mice compared to age-matched sham mice
(Figure 2C). Although statistically insignificant, urinary excretions of 2’-deoxycytidine at
D0 at eight months were 1.8-fold (p = 0.051) lower than that at two months of age. The
urinary excretions of 2’-deoxycytidine in the Rad-2 and Rad-1 group of mice after exposure
at eight months were 8-fold and 6.7-fold higher than the sham mice (Figure 2D). There was
no significant difference between Rad-1 and Rad-2 groups with respect to urinary excretion
of this metabolite following radiation exposure at eight months, in spite of Rad-2 receiving a
previous exposure. However, the urinary excretion of 2’-deoxycytidine in the Rad-2 and
Rad-1 groups were, respectively, 1.8-fold (p < 0.05) and 1.5-fold (p < 0.05) higher than that
of the Rad-4 group. These results indicated that repeated exposure contributes more
significantly to the attenuation in elevation of 2’-deoxycytidine excretion compared to
aging.
The urinary excretion of thymidine was elevated by 8.4-fold (p < 0.005), 16.7-fold (p <
0.005), 3.8-fold (p < 0.005) and 6.1-fold (p < 0.01) after exposures (D0), respectively, at
two, four, six and eight months of age in the Rad-4 group of mice compared to age-matched
sham mice (Figure 2D). Although, thymidine excretions on D0 at six and eight months were
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lower than that at two and four months, the attenuation was not statistically significant. The
urinary excretions of thymidine in the Rad-2 and Rad-1 group of mice after exposure at
eight months were 13.4-fold (p < 0.005) and 6.7- fold (p < 0.01) higher than that of the sham
mice (Figure 2E). Thymidine excretion in Rad-2 group was 2.2-fold higher (P < 0.05) than
that in Rad-4 group at eight months. However, there was no significant difference between
urinary excretion of this metabolite between the Rad-2 and Rad-1 group as well as between
the Rad-4 and Rad-1 group at this age. These results indicated that repeated exposure
contributes more significantly to the attenuation in elevation in excretion of thymidine
compared to aging.
The urinary excretion of xanthine was elevated by 3.7-fold (p < 0.005), 3.8-fold (p < 0.005),
3.9-fold (p < 0.005) and 4.7-fold (p < 0.02) after exposures (D0), respectively, at two, four,
six and eight months of age in Rad-4 group of mice compared to age-matched sham mice
(Figure 3A). The urinary excretion of xanthine on D0 at six and eight months of age were,
respectively, 1.6-fold (p <0.03) and 2.1-fold (p < 0.004) lower than that at two months of
age. The urinary excretions of xanthine in the Rad-2 and Rad-1 group after exposure at eight
months were, respectively, 6.1-fold (p < 0.008) and 4.3-fold (p <0.02) higher than that of
sham mice (Figure 3B). However, there was no significant difference in excretion of
xanthine among Rad-1, Rad-2 and Rad-4 groups that received their first, second and fourth
exposure, respectively, at eight months. These results indicated that aging contributes more
significantly to the attenuation of elevation in excretion of xanthine compared to repeated
exposure.
The urinary excretion of xanthosine was elevated by 2.2-fold (p < 0.03), 1.7-fold (p < 0.01)
and 1.9-fold (p < 0.005) after exposures (D0), respectively, at two, four and six months of
age in the Rad-4 mice compared to age-matched sham mice (Figure 3C). However, the
elevation in xanthosine excretion at eight months of age was insignificant in Rad-4 as well
as Rad-1 group of mice (Figure 3D). Although Rad-2 group of mice showed 1.7-fold (p <
0.05) elevation in xanthosine excretion compared to sham mice at eight months, they were
not significantly different from the Rad-1 and Rad-4 group. These results indicated that
attenuation of elevation in excretion of xanthosine is mostly due to aging rather than
repeated exposure.
N1-acetylspermidine excretion was elevated by 2.5-fold (p < 0.005), 2.1-fold (p < 0.005),
1.9-fold (p < 0.005) and 1.9-fold (p < 0.02) after exposures (D0) at two, four, six and eight
months of age in Rad-4 group of mice compared to age-matched sham mice (Figure 4A).
The urinary excretion of N1-acetylspermidine on D0 at four, six and eight months were,
respectively, 1.6-fold (p < 0.03), 2.1-fold (p < 0.001) and 2.4-fold (p <0.002) lower than that
at two months of age. N1-acetylspermidine excretion in the Rad-2 and Rad-1 mice after
exposure at eight months were 2.2-fold (p < 0.005) and 2-fold (p <0.02) higher than that of
the sham mice (Figure 4B). Excretion of N1-acetylspermidine in Rad-1 mice at eight months
was also 2.3-fold (p <0.005) lower than after the first exposure of the Rad-4 animals at two
months. However, there was no significant difference in excretion of N1-acetylspermidine
among Rad-1, Rad-2 and Rad-4 groups that received their first, second and fourth exposure,
respectively, at eight months. These results indicated that the elevation of N1-
acetylspermidine excretion is attenuated by aging.
The urinary excretion of putrescine was depleted by 1.6-fold (p < 0.03), 1.3-fold (p < 0.01),
and 1.4-fold (p < 0.005), respectively, after exposures (D0) at two, six and eight months of
age in Rad-4 group of mice compared to age-matched sham mice (Figure 4C). Putrescine
excretions in the Rad-2 and Rad-1 mice after exposure at eight months were 1.3-fold (p <
0.005) and 1.9-fold (p <0.005) lower than that of the sham mice (Figure 4D). In addition, the
Rad-1 group was found to have 1.3-fold (p < 0.03) and 1.5-fold (p < 0.02) lower excretion
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of putrescine compared to the Rad-4 and Rad-2 groups, respectively. These results indicated
that depletion in putrescine excretion may be affected by repeated exposure.
N1-Acetylspermidine is the downstream metabolite of putrescine in the polyamine metabolic
pathway. The ratio of N1-acetylspermidine to putrescine in the urine of the Rad-4 group
was, respectively, 4-fold (p < 0.005), 2.6-fold (p < 0.005), 2.5-fold (p < 0.005) and 2.7-fold
(p < 0.005) higher than that of the sham mice on D0 at two, four, six and eight months
(Figure 4E). The ratio of these two metabolites at four, six and eight months were,
respectively, 2.1-fold (p <0.04), 3.1-fold (p <0.02), and 3.2-fold (p <0.03) lower than that at
two months in the Rad-4 group. The ratios at six and eight months were also 1.5-fold (p <
0.01) and 1.6-fold (p < 0.02) lower than that at four months in this group. The ratios of these
metabolites in Rad-2 and Rad-1 group of mice after exposure at eight months were,
respectively, 2.9-fold (p < 0.005) and 4.1-fold (p <0.005) higher than that of the sham mice
(Figure 4F). Post-exposure putrescine-normalized excretion of N1-acetylspermidine in
Rad-1 mice at eight months was also 2.1-fold (p <0.02) lower than after first exposure of
Rad-4 animals at two months. However, there was no significant difference between
putrescine-normalized excretion of N1-acetylspermidine in Rad-1, Rad-2 and Rad-4 groups
that received their first, second and fourth exposure, respectively, at eight months. These
results indicated that the elevation in putrescine-normalized excretion of N1-
acetylspermidine is attenuated by aging. Excretion of ornithine, dimethylarginines, creatine
and pimelic acid did not show any consistent change following radiation exposure
throughout the study.
These results showed that while elevation of 2’-deoxyuridine, xanthine, xanthosine, N1-
acetylspermidine and the ratio of N1-acetylspermidine to putrescine were mainly attenuated
by aging, repeated exposure contributed more significantly to the attenuation of 2’-
deoxycytidine and thymidine. However, in spite of the attenuation, changes in all
biomarkers were still significant in mice that were older as well as those receiving multiple
exposures.
Predictive power of the urinary radiation biomarkers
The ROC analysis was performed to assess the utility of individual metabolites in predicting
radiation exposure status. The area under the ROC curve for 2’-deoxyuridine was found to
be 1.0 at two (six sham and six R-4 animals), four (six sham and six R-4 animals), six (six
sham, six R-2 and six R-4 animals) as well as eight months of age (six sham, six R-1, six
R-2 and six R-4 animals) (Figure S3). The ROC analysis including sham and irradiated
animals from all exposure and age groups showed an area under the curve of 0.997 with
98% accuracy of identifying radiation exposure using 2’-deoxyuridine as a noninvasive
biomarker (Figure 5A). The area under the ROC curve for deoxycytidine was found to be
1.0, 0.943, 0.958 and 1.0 at two, four, six and eight months, respectively (Figure S3). The
ROC analysis including sham and irradiated animals from all exposure and age groups
showed an area under the curve of 0.983 with 92% accuracy of identifying radiation
exposure using deoxycytidine as a noninvasive biomarker (Figure 5A). The area under the
ROC curve for thymidine was found to be 1.0, 0.943, 0.986 and 0.983 at two, four, six and
eight months, respectively (Figure S3). The ROC analysis including sham and irradiated
animals from all exposure and age groups showed an area under the curve of 0.965 with
92% accuracy of identifying radiation exposure using thymidine as a noninvasive biomarker
(Figure 5A). The area under the ROC curve for xanthine was found to be 1.0, 0.971, 0.931
and 0.944 at two, four, six and eight months, respectively (Figure S3). The ROC analysis
including sham and irradiated animals from all exposure and age groups showed an area
under the curve of 0.94 with 88% accuracy of identifying radiation exposure using xanthine
as a noninvasive biomarker (Figure 5B). The area under the ROC curve for xanthosine was
found to be 0.889, 0.971, 0.986 and 0.778 at two, four, six and eight months, respectively
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(Figure S3). The ROC analysis including sham and irradiated animals from all exposure and
age groups showed an area under the curve of 0.868 with 82% accuracy of identifying
radiation exposure using xanthosine as a noninvasive biomarker (Figure 5A). The area under
the ROC curve for N1-acetylspermidine was found to be 1.0 at all time points except at six
months (0.935) (Figure S3). The ROC analysis including sham and irradiated animals from
all exposure and age groups showed an area under the curve of 0.92 with a 92% accuracy of
identifying radiation exposure using N1-acetylspermidine as a noninvasive biomarker
(Figure 5C). The area under the ROC curve for putrescine was found to be 0.889, 0.971,
0.986 and 0.778 at two, four, six and eight months, respectively (Figure S3). The ROC
analysis including sham and irradiated animals from all exposure and age groups showed an
area under the curve of 0.868 with 82% accuracy of identifying radiation exposure using
putrescine as a noninvasive biomarker (Figure 5C). The area under the ROC curve for
detection of radiation exposure using N1-acetylspermidine to putrescine ratio as a
noninvasive signature was found to be 1.0 at all time points except at six months (0.943)
(Figure S3). Consequently, the ROC analysis including sham and irradiated animals from all
exposure and age groups showed an area under the curve of (0.956) and accuracy (94%),
which was higher than that achieved using N1-acetylspermidine and putrescine as individual
markers for identifying radiation exposure (Figure 5C).
Correlation between changes in urinary radiation biomarker excretion
Although most of the metabolites showed a significant change in excretion upon irradiation
and, consequently, very high ability to identify radiation exposure, there was considerable
inter-individual variations in the elevation of urinary biomarkers among exposed mice. It
was noted that this variation did not correlate with the body weight of the animals (data not
shown) indicating that area of exposure is not the determining factor in the observed
variation. In order to reveal possible collusion between metabolic events in response to
radiation exposure in the context of aging, the correlation between changes in metabolites in
same set of animals (Rad-4 group) at different ages were examined. Since elevation in 2’-
deoxyuridine was found to be the most robust signature of radiation exposure, correlations
between changes in other biomarkers and that of 2’-deoxyuridine were examined. The
elevation of 2’-deoxycytidine excretion was highly correlated with that of 2’-deoxyuridine
with correlation coefficients (R2) of 0.81 (p < 0.006), 0.75 (p < 0.002), 0.92 (p < 0.0007)
and 0.72 (p < 0.02), respectively, at two, four, six and eight months (Figure 6A). The
elevation of thymidine excretion was highly correlated with that of 2’-deoxyuridine with R2
of 0.80 (p < 0.008), 0.90 (p < 0.002), 0.62 (p < 0.04) and 0.85 (p < 0.004) at two, four, six
and eight months, respectively (Figure 6B). The correlation coefficients between elevation
of N1-acetylspermidine and deoxyuridine at two, four, six and eight months were 0.66 (p <
0.03), 0.86 (p < 0.003), 0.65 (p < 0.03), 0.87 (p < 0.003), respectively (Figure 6C). The
correlation between elevation of xanthine and 2’-deoxyuridine were found to be very high at
two months with R2 0.97 (p < 0.0001) (Figure 6D). However, the correlation was poorer, in
general, for older mice with correlation coefficient of 0.67 (p < 0.03) and 0.62 (p < 0.04),
respectively, at four and eight months and no significant correlation at six months. The
correlation between xanthine and N1-acetylspermidine elevation was also relatively poorer,
in general, and insignificant in older mice. The correlation coefficients between elevation of
these two metabolites were found to be 0.60 (p < 0.05), 0.58 (p < 0.05) at two and four
months, respectively. At six and eight months, this correlation was not statistically
significant. There was no significant correlation between the excretion of xanthosine and
other metabolites (data not shown).
These results indicate that elevation in production of pyrimidine metabolites (2’-
deoxyuridine, 2’-deoxycytidine and thymidine) are tightly coupled between themselves as
well as with N1-acetylspermidine. On the other hand, elevation of the purine metabolites
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was either not correlated (xanthosine) or showed very poor correlation (xanthine) with
elevation of pyrimidine metabolites and N1-acetylspermidine, particularly, in older mice.
DISCUSSION
In addition to the well-known γH2AX and dicentric chromosome assay, recent studies have
revealed metabolome signatures of exposure to ionizing radiation in serum19,20. However,
urine-based biomarkers are very attractive due to the ease and noninvasiveness of the
collection procedure. In addition, the fact that these biomarkers originate from DNA
damage, which is a well-established consequence of radiation exposure, and some of them
were shown to be elevated in urine from non-human primates13, which are genetically very
close to humans, as well as in human skin samples21 following irradiation, increases the
likelihood of translation into viable biomarkers for human exposure. This study showed that
elevation of these urinary metabolomic biomarkers are robust signatures of radiation
exposure irrespective of aging and history of previous exposures in mice. However, it was
found that the elevation of these biomarkers was significantly attenuated with aging. In
addition, in the case of older mice (8 months) there was some significant attenuation in the
elevation of thymidine and deoxycytidine in mice with a history of previous exposure
compared to newly exposed mice. However, there was no difference in the elevation of
xanthine, N1-acetylspermidine and the ratio of N1-acetylspermidine and putrescine in older
mice due to previous exposure. This suggests that these three metabolites could be used to
determine level of exposure if the age of the subject is known subject to establishment of an
age-adjusted dose-response curve. In addition, a concomitant attenuation of thymidine and
deoxycytidine excretion without any significant difference in level of xanthine, N1-
acetylspermidine and ratio of N1-acetylspermidine to putrescine compared to other age-
matched exposed subjects could yield unbiased information about previous exposure. These
data are extremely important in the context of risk assessment and stratification for
appropriate post-exposure intervention. Thus, these results indicate that detailed dose-
response studies on the effect of aging and previous exposure on noninvasive metabolomic
biomarkers of radiation exposure may help to develop methods for rapid identification of
exposed subjects as well as for risk assessment according to age and exposure history.
However, the overall attenuation in metabolic response due to repeated exposure at long
intervals was not as drastic as that caused by aging. The non-uniformity of attenuation of
metabolites also indicates that prior exposure-related tissue depletion may not be the reason
for the observed changes.
Radiation exposure is well known to cause DNA damage22–25. In fact, DNA damage-related
changes such as phosphorylation of H2AX at Ser-139 (γ-H2AX)1 and the dicentric
chromosome assay8 have been established as the most reliable signatures of radiation
exposure. Radiation was shown to cause DNA damage by production of ROS such as
hydroxyl radical or by direct cleavage of covalent bonds in DNA molecule22–25.
Modification of DNA bases and sugars are major ways of DNA damage due to radiation
exposure and ROS production, in addition to single and double-strand breaks6,26,27. Under
normal conditions, cells recognize such changes and activate a cascade of signaling events
that either leads to apoptosis or cell cycle arrest28. During cell cycle arrest, a complex
machinery of enzymes is recruited depending on the type of DNA damage. The damaged
lesions are eventually repaired to restore the original sequence (except in the case of non-
homologous end-joining) by removal of damaged DNA and joining broken strands27–29.
The damaged DNA products such as bases or nucleosides are removed through base-
excision repair or nucleoside excision repair28,30–32. It was shown that oxidatively modified
DNA bases can be excreted in urine as 2’-deoxyribonucleosides during the DNA damage-
repair process33. Therefore, it is not surprising to find that the origin of most of the urinary
biomarkers reported in this study lies in nucleic acid metabolism. Apart from animal models,
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such markers that potentially arise from DNA damage have also been shown to be elevated
after exposure of human skin tissue to low-dose gamma radiation21. The damaged nucleic
acids are eventually metabolized and excreted. These indicate DNA damage to be the origin
of urinary biomarkers such as 2’-deoxyuridine, 2’-deoxycytidine and thymidine.
Cytosine, which is frequently converted to uracil under oxidative stress, is one of the most
sensitive bases to oxidative DNA damage29. Such modification can cause introduction of
G→A mutations in DNA if replication continues without repair. The current as well as
earlier radiation metabolomics studies has shown significant elevation in urinary excretion
of the pyrimidine 2’-deoxyribonucleosides, such as thymidine, deoxyuridine and
deoxycytidine10,13. It was noted that the elevation of 2’-deoxyuridine was highly correlated
with that of 2’-deoxycytidine. As shown in Figure 7A, this may reflect possible conversion
of 2’-deoxycytidine to 2’-deoxyuridine due to cytidine deaminase (EC 3.5.4.5) activity. 2’-
Deoxyuridine could also be converted to thymidine via a rescue mechanism involving
thymidine kinase (EC 2.7.1.21) and thymidilate synthase (EC 2.1.1.45). This could explain
the strong correlation between thymidine and 2’-deoxyuridine excretion. The fact that the
correlation between 2’-deoxyuridine, 2’-deoxycytidine and thymidine excretion was strong
in spite of significant attenuation of the level of elevation, indeed, indicate to a biochemical
link between production of these pyrimidine 2’-deoxynucleosides in response to exposure to
ionizing radiation.
Putrescine clearance was found be attenuated after radiation exposure. This may be due to
conversion putrescine to N1-acetylspermidine, which was elevated in the urine after
exposure. N1-acetylspermidine is produced by the addition of a propylamine group onto
putrescine by spermidine synthase (EC 2.5.1.16) followed by acetylation by spermine/
spermidine acetyl transferase (EC 2.3.1.57) as shown in Figure 7B. It was observed that
similar to the pyrimidine 2’-deoxynucleosides, N1-acetylspermidine elevation was
attenuated with aging but remained highly correlated with that of deoxyuridine. This
suggests a potential biochemical link between elevation of N1-acetylspermidine and
pyrimidine 2’-deoxynucleosides generated during DNA damage-repair. It was also
interesting to note that ROC analysis indicated that the ratio of excretion of N1-
acetylspermidine and putrescine was a more robust signature of radiation exposure than the
individual metabolites. This ratio essentially indicates the flux through polyamine
biosynthesis towards production of acetylated polyamines. Whereas polyamines have been
shown to promote proliferation, polyamine catabolism through acetylation has been shown
to attenuate it34, 35. Cells need to halt proliferation in order to efficiently repair DNA
damage caused by radiation exposure. Depletion of the polyamine pool would help cells to
achieve lower proliferation rates and propagation of fewer mutations during subsequent
replication. Thus, an increase in polyamine acetylation may be an integral part of effective
cellular response to oxidative DNA damage, which is reflected by the urinary metabolomic
signature. The fact that inter-individual variation in the elevation of 2’-deoxyuridine, a
metabolic by-product of oxidative DNA-damage repair, was strongly correlated with that in
elevation of polyamine acetylation, further supports this hypothesis. If this hypothesis is
true, attenuation in elevation of polyamine acetylation would result in inefficient arrest of
the cell cycle and, thereby, inefficient oxidative DNA damage repair. Consequently, one
would expect a decline in clearance of metabolites resulting from oxidative DNA damage
such as 2’-deoxyuridine. It was noted that elevation in polyamine acetylation was
significantly attenuated with aging with a concomitant and correlated attenuation in
excretion of 2’-deoxyuridine. It has been well documented that aging attenuates the ability
to fight oxidative stress and reduces DNA damage repair efficiency6,36,37. In fact, similar to
the observations reported in this study, DNA repair activity through base and nucleotide
excision repair in human skin fibroblasts were affected by aging but not by chronic
photoexposure37. Thus these results indicate that attenuation of polyamine metabolism may
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contribute to the decline of DNA damage-repair efficiency and accumulation of somatic
mutation in older animals as shown in Figure 7C.
Radiation exposure also caused significant elevation of xanthine and xanthosine. Xanthine
has been shown to be elevated in human skin tissue after low-dose ionizing radiation
exposure21. Nucleotide excision repair can produce purine 2’-deoxyribonucleosides such as
2’-deoxyadenosine and 2’-deoxyguanosine. These 2’-deoxyribonucleosides can be
deconjugated to their corresponding bases adenine and guanine by purine nucleoside
phosphorylase (EC 2.4.2.1). Guanine can be converted to xanthine by guanine deaminase
(EC 3.5.4.3). Adenine can be conjugated with ribose by purine nucleoside phosphorylase to
produce adenosine that can be deaminated by adenine deaminase (EC 3.5.4.4) to inosine.
Inosine can be converted to xanthine by the action of enzymes purine nucleoside
phosphorylase and xanthine oxidase (EC 1.17.3.2) or xanthine dehydrogenase (EC 1.17.1.4)
with production of hypoxanthine as an intermediate (Figure 7A). Both inosine and
hypoxanthine was shown to be elevated in irradiated human skin tissue21. Guanine can also
be conjugated to guanosine by purine nucleoside phosphorylase. It was shown earlier that
guanine deaminase from human liver can directly convert guanosine to xanthosine38, which
was found to be elevated after radiation exposure. The lack of correlation between xanthine
and xanthosine excretion may be a reflection of the fact that a number of additional
pathways contribute to xanthine production. Consequently, xanthine was found to be the
major purine metabolite that was elevated in response to radiation exposure. Similar to
pyrimidine metabolites, xanthine also showed a significant correlation with N1-
acetylspermidine levels in younger mice, but not in older ones. The younger mice also
showed a significant correlation between clearance of the major purine metabolite xanthine
and that of modified pyrimidines such as 2’-deoxyuridine. However, this correlation was
poor in older mice. In the absence of drastic changes in composition due to mutations, the
purine and pyrimidine content of DNA is expected to remain constant throughout life.
Assuming that the propensity of purine and pyrimidine nucleotides to undergo oxidative
damage following radiation exposure, which is determined by their chemical reactivity,
remain constant throughout life, the clearance of these metabolites should be determined by
the efficiency of DNA damage repair. It is known that DNA damage repair ability is
attenuated with aging. However, if the relative efficiency of repair of purine and pyrimidine
modification is attenuated coherently (through the same mechanism) during aging, the
elevation in xanthine and 2’-deoxyuridine would be attenuated but would remain correlated.
However, the fact that their correlation was also poor in older mice, thus, indicates that the
machinery involved in repair of purine and pyrimidine damage-repair is affected differently
by aging. Such deficiency in repair of different types of DNA damages may further
contribute to the accumulation of mismatches in older mice. Since, attenuation of polyamine
catabolism with aging could also contribute to inefficient cell cycle arrest, which is essential
for DNA damage repair; such mismatches would result in accumulation of somatic
mutations in proliferating cells from older mice.
Thus, the results presented in this study shows that both attenuation of polyamine catabolism
and loss of coherence between DNA damage repair mechanisms may contribute to
attenuation in the ability of older mice to negotiate oxidative insults caused by radiation
exposure and lead to the accumulation of somatic mutations. Accumulation of somatic
mutation during aging due to chronic oxidative stress plays a major role in aberration
cellular phenotype6,36,39,40. This eventually and stochastically results in pathogenesis of
number of diseases including cancer. Therefore, the observations presented here invites
detailed investigation into interaction of polyamine metabolism and DNA damage repair
pathways. Future studies into this aspect may not only enrich our understanding of the
chemical biology of DNA damage repair but also provide novel strategies to mitigate the
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challenges posed by an aging world population as well as increasing exposure to oxidative
stress due to environmental and life-style-related factors.
Conclusion
This study showed that repeated exposure and, more importantly, aging, attenuates changes
in the urinary metabolomic response to radiation exposure. Nevertheless, the metabolomic
signature was robust enough to identify exposed animals irrespective of their age and history
of previous exposure. In addition, comparative analysis of elevation in excretion of radiation
biomarkers in age-matched subject may also help in extracting information about previous
exposures. Thus, this study showed that metabolomic alterations could be used to
noninvasively screen and triage exposed subjects from a heterogeneous population
following an accidental radiation release. Finally, the analysis of the effect of aging on the
metabolic fingerprint also indicated to a novel link between polyamine metabolism and
DNA damage repair.
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Figure 1. Metabolomic study design and multivariate data analysis
(A) Rad-4 group of mice received four exposures (3 Gy; 1.16Gy/min from a 137Cs source) at
2, 4, 6, and 8 months of age. Rad-2 group of mice received two exposures at 6 month and 8
months of age. Rad-1 group of mice received one exposure at 8 months of age. (B) Mice
were rested for 24 hours in their regular housing cages between 24-hour urine collections in
metabowls on D-2, D0, and D2. At D0 mice were placed into metabolic cages immediately
after exposure and urine collected for 24 hours. (C) Scores scatter plot generated from PCA
of global metabolomic signatures of urine samples collected at D0 and recorded in ESI+
mode showing unsupervised clustering of sham (black) and irradiated (red) mice at 2 months
(circle), 4 months (square), and 6 months (triangle) of age. The arrow shows the metabotype
shift due to radiation exposure. (D) PCA scores scatter plots showing unsupervised
segregation of the Rad-4 group of animals after the first (2 months), second (4 months), and
third (6 months) exposures and that of Rad-2 mice after the first (6 months) exposure. (E)
Loading S-plot generated from OPLS-DA including all irradiated and sham samples up to
six months of age.
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Figure 2. Effect of aging and repeated radiation exposure on pyrimidine metabolites
Temporal evolution of creatinine-normalized (A) 2’-deoxyuridine, (C) 2’-deoxycytidine and
(E) thymidine excretion over the first (2 months), second (4 months), third (6 months), and
fourth (8 months) exposures of the Rad-4 group (●, solid line) are shown along with sham
(○, dotted line) mice. Although excretion levels between exposures (e.g., D2 at two month
and D-2 at 4 months) are joined by straight lines no urine samples were collected during
these rest periods. Significant elevations in metabolite excretion following radiation
exposure (D0) compared to age-matched sham-mice are indicated (*). Significant decreases
in excretion of the metabolite over time are indicated (#). The creatinine-normalized
excretion of (B) 2’-deoxyuridine, (D) 2’-deoxycytidine and (F) thymidine from Rad-1 (▲)
mice, the second exposure of Rad-2 (■) mice, fourth exposure Rad-4 (●) mice, and sham
mice (○) at 8 months of age. Significant differences between D0 Rad-1 (*) and Rad-2 (#)
and age-matched sham mice are indicated. In addition, $ next to * and #, respectively,
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indicates that excretion of the metabolite in Rad-1 and Rad-2 group was also significantly
different than age-matched Rad-4 mice. Statistical significance for graphs (A), (C), and (E)
was calculated by paired t test. The statistical significance for graphs (B), (D), and (F) was
calculated by two-tailed Mann-Whitney test with 95% confidence interval. P value < 0.05
was considered significant.
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Figure 3. Effect of aging and repeated radiation exposure on purine metabolites
Temporal evolution of creatinine-normalized (A) xanthine and (C) xanthosine excretion
during the first (2 months), second (4 months), third (6 months) and fourth (8 months)
exposures of Rad-4 group (●, solid line) are shown along with sham (○, dotted line) mice.
Although the excretion level between exposures (e.g., D2 at two month and D-2 at four
month) are joined by straight lines no urine samples were collected during these rest periods.
Significant elevations in metabolite excretion following radiation exposure (D0) compared
to age-matched sham-mice are indicated (*). Significant decreases in excretion of the
metabolite over time are indicated (#). The creatinine-normalized excretion of (B) xanthine
and (D) xanthosine from Rad-1 (▲), the second exposure of Rad-2 (■), fourth exposure
Rad-4 (●), and sham (○) at 8 months of age. Significant differences between D0 Rad-1 (*)
and Rad-2 (#) and age-matched sham mice are indicated. Statistical significance for graphs
(A) and (C) was calculated by paired t test. The statistical significance for graphs (B) and
(D) was calculated by two-tailed Mann-Whitney test with 95% confidence interval. P value
< 0.05 was considered significant.
Manna et al. Page 18
J Proteome Res. Author manuscript; available in PMC 2014 May 03.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4. Effect of aging and repeated radiation exposure on polyamine metabolites
Temporal evolution of creatinine-normalized (A) N1-acetylspermidine, (C) putrescine
excretion and (E) ratio of excretion of N1-acetylspermidine with respect to putrescine during
the first (2 months), second (4 months), third (6 months) and fourth (8 months) exposures of
Rad-4 group (●, solid line) are shown along with sham (○, dotted line) mice. Although
excretion levels between exposures (e.g., D2 at two month and D-2 at four month) are joined
by straight lines no urine samples were collected during these rest periods. Significant
differences in metabolite excretion following radiation exposure (D0) compared to age-
matched sham-mice are indicated (*). Significant decreases in excretion of the metabolite
over time are indicated (#). The creatinine-normalized (B) N1-acetylspermidine, (D)
putrescine excretion and (F) the ratio of N1-acetylspermidine excretion normalized to
putrescine from Rad-1 (▲), second exposure of Rad-2 (■), fourth exposure of Rad-4 (●),
and sham (○) mice at 8. Significant differences between D0 Rad-1 (*) and Rad-2 (#) and
Manna et al. Page 19
J Proteome Res. Author manuscript; available in PMC 2014 May 03.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
age-matched sham mice are indicated. In addition, $ next to * indicates that excretion of the
metabolite in Rad-1 group was also significantly different than age-matched Rad-4 mice.
The statistical significance of difference in metabolite excretion in different group of mice
were calculated by two-tailed Mann-Whitney test with 95% confidence interval and the
significance in difference in excretion of metabolites in mice from Rad-4 group during
different exposures were calculated by paired t test. P value < 0.05 was considered
significant. Statistical significance for graphs (A), (C), and (E) was calculated by paired t
test. The statistical significance for graphs (B), (D), and (F) was calculated by two-tailed
Mann-Whitney test with 95% confidence interval. P value < 0.05 was considered significant.
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Figure 5. Predictive power of noninvasive biomarkers
Receiver operating characteristic (ROC) curves for evaluating the accuracy of radiation
exposure prediction by logistic regression of the level of urinary excretion of (A)
pyrimidine, (B) purine, and (C) polyamine metabolites. The analysis was performed
including all post-exposure samples from sham, Rad-1, Rad-2, and Rad-4 groups
irrespective of age and history of exposure. The area under the curve and accuracy of
prediction is indicated on each ROC curve.
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Figure 6. Analysis of correlation between metabolomic response originating from different
biochemical pathways
Correlation between excretion of the most predictive metabolite 2’-deoxyuridine with that of
other pyrimidine metabolites such as (A) 2’-deoxycytidine, (B) thymidine, the polyamine
metabolite (C) N1-acetylspermidine and purine metabolite (D) xanthine is shown. The
linearity between excretion of these biomarkers during consecutive exposure of Rad-4
animals at 2, 4, 6, and 8 months were examined. Pearson correlation coefficients at
respective ages are indicated along with P values on the plots.
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Figure 7. Biochemical pathway involved in production of radiation exposure biomarkers related
to (A) nucleic acid metabolism and (B) polyamine metabolism
Quantitatively elevated and depleted metabolites are shown in red and blue, respectively,
while grey metabolites indicate no change or not measured in this study. Possible chemical
modification of DNA contributing to production of these metabolites is shown with red
bases indicating base modification (such as C→U) and red boxes indicating nucleotide
excision sites following single-strand breaks. The enzymes involved in these metabolic
pathways such as cytidine deaminase (EC 3.5.4.5), thymidine kinase (EC 2.7.1.21),
thymidylate synthase (EC 2.1.1.45), 5',3'-nucleotidase (mitochondrial) (EC 3.1.3.5), purine-
nucleoside phosphorylase (EC 2.4.2.1), guanine deaminase (EC 3.5.4.4), adenine deaminase
(EC 3.5.4.3), xanthine dehydrogenase (EC 1.17.3.2), xanthine oxidase (EC 1.17.1.4),
ornithine decarboxylase (EC 4.1.17), spermidine synthase (EC 2.5.1.16) and spermidine/
spermine N1-acetyltransferase (EC 2.3.1.57) are indicated next to corresponding steps
(shown by solid grey arrow). Lines with arrows in both directions for purine-nucleoside
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phosphorylase indicate its ability to catalyze ribosyltransferase activity in both directions.
Dotted grey arrow indicates that the corresponding enzymatic activity has not been reported
in mice. (C) Putative mechanism showing the role of polyamine catabolism in radiation-
induced damage-repair through cell cycle arrest and the effect of aging in the process. Dark
red asterisk indicate DNA damage lesion caused by radiation exposure that would cause
mutation if replicated without repair during proliferation. Faint red asterisk encircled by
black circles indicate recruitment of DNA-damage repair machinery during cell cycle arrest
leading to successful DNA damage repair. Attenuation of polyamine catabolism in older
mice may lead to inefficient arrest of cell cycle and, thus, impairment of DNA damage
repair and propagation of mutation in proliferating somatic cells.
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